Medtronic plc (MDT)

79.62 0.47%
Dec 05 close; Powered by Koyfin
Pros
Stock price low relative to the 52-week range
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Forward P/E ratio low relative to industry peers
Forward P/B ratio low relative to industry peers
Forward P/S ratio low relative to industry peers
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages

Pros

  1. MDT stock price ($79.62) is close to the 52-week low ($76.13). Perhaps now is a good time to buy? See MDT price chart.
  2. MDT profitability is improving. The YoY profit margin change was 10.36 percentage points. See MDT profitability chart.
  3. MDT forward dividend yield is 3.19%, higher than the industry (0.15%) and sector (0.20%) forward dividend yields. See MDT forward dividend chart.
  4. MDT forward P/E ratio is 13.92, which is low compared to its industry peers’ P/E ratios. See MDT forward P/E ratio chart.
  5. MDT Price/Book ratio is 2.11, which is low compared to its industry peers’ P/B ratios. See MDT forward Price/Book ratio chart.
  6. MDT Price/Sales ratio is 3.45, which is low compared to its industry peers’ P/S ratios. See MDT forward Price/Sales ratio chart.
  7. MDT PEG ratio (P/E adjusted for growth) is 1.22, which is low compared to its industry peers’ PEG ratios. See MDT PEG chart.
  8. MDT average analyst rating is Buy. See MDT analyst rating chart.
  9. MDT average analyst price target ($103.06) is above its current price ($79.62). See MDT price target chart.

Cons

  1. MDT quarterly revenue growth was -7.70%, lower than the industry and sector average revenue growth (7.64% and 6.06%, respectively). See MDT revenue growth chart.